Atlas of Atherosclerosis

Risk Factors and Treatment

  • Peter W. F. Wilson

Table of contents

  1. Front Matter
    Pages i-xi
  2. Michael B. Gravanis
    Pages 1-19
  3. Noyan Gokce, Joseph Loscalzo
    Pages 21-40
  4. G. M. Anantharamaiah, David W. Garber, Jere P. Segrest
    Pages 51-67
  5. Ngoc-Anh Le, W. Virgil Brown
    Pages 69-93
  6. Sampath Parthasarathy
    Pages 95-114
  7. H. Bryan Brewer Jr.
    Pages 115-131
  8. Alice H. Lichtenstein, Alan Chait, Michael E. Rosenfeld
    Pages 133-164
  9. Evan A. Stein
    Pages 165-191
  10. Peter W. F. Wilson
    Pages 193-211
  11. Ira J. Goldberg, Clay F. Semenkovich, Henry N. Ginsberg
    Pages 213-233
  12. Paul A. Heidenreich, Harlan M. Krumholz
    Pages 259-272
  13. Back Matter
    Pages 273-284

About this book


We are in the early years of a new millen­ Tremendous interest is now focused on nium and atherosclerotic disease is now the characteristics of atherosclerotic thought to underlie more adult deaths plaques, as we recognize that many clinical than any other disease on the planet. The coronary events are attributable to unstable lifetime burden of risk is high, and lesions that do not cause severe stenoses but Framingham data suggest that approxi­ are prone to rupture and precipitate angina mately 50% of men and 30% of women pectoris or a myocardial infarction. A vari­ will experience coronary heart disease ety of factors are under study to help deter­ during their lifetime. This process begins mine what affects the balance between at a young age, and autopsies of casualties plaque stability and instability. Some of this from the Korean and Vietnam wars as well research is fueled by the fact that therapy for as accident victims in more recent times dyslipidemia often has effects that are not have shown that fatty streak lesions are related to the lipoprotein cholesterol alter­ very common in young adults. Recent ations, but stem from the pleiotropic effects research has extended these pathologic of such medications on hematologic and studies to investigate the dynamics and inflammatory mechanisms. milieu that foster the creation of these The current volume focuses on the early lesions.


Lipoprotein atherosclerosis cardiovascular high-density lipoprotein (HDL) vascular disease

Editors and affiliations

  • Peter W. F. Wilson
    • 1
    • 2
  1. 1.Boston University School of MedicineBostonUSA
  2. 2.Framingham Heart StudyFraminghamUSA

Bibliographic information

  • DOI
  • Copyright Information Current Medicine Group 2003
  • Publisher Name Current Medicine Group, London
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4615-6486-7
  • Online ISBN 978-1-4615-6484-3
  • Buy this book on publisher's site